|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The N a (+) 2K (+) 2 ATP ase alpha2 gene and trainability of cardio respiratory endurance: the HER ITA GE family study 显示文摘 | Rankinen T Perusse L Bo reck i I | 2000 | J Appl Physiol2000，，1： | 1 |
| 2 | Ipilimumab in combination with paclitaxeland carboplatin as first-line therapy in extensive-dis- ease-small-cell lung cancer: results from a randomized, double- blind, multicenter phase 2 trial显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann Oncol2013，24，1： | 1 |
| 3 | Ipilimumab in combination with pac litaxel and carboplatin as first-line therapy in extensive- disease-small-cell lung cancer:, results from a randomized, double-blind, multicenter phase 2 trial显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann Oncol2013，24，1： | 1 |
| 4 | Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer:results from a randomized,double-blind,multicenter phase 2 trial 显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann Oncol2013，24，1： | 1 |
| 5 | Ipilimumab in com- bination with paclitaxel and carboplatin as first-line ther- apy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 tri- M 显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann Onco12013，24，1： | 1 |
| 6 | Ipilimumab ineombination with paclitaxel and carboplatin as first-line therapy in extensive disease small-cell lung cancer: results from a randomized, double-blind, muhicenter Phase 2 trial 显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann Oneol2013，24，1： | 1 |
| 7 | Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial 显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann Oncol2013，24，1： | 1 |
| 8 | Ipilimumab in combination with paclitaxel and carboplatin as first - line therapy in extensive - disease - small - ceil lung cancer: results from a randomized, double -blind, multicenter phase 2 trial 显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann Oncol2013，24，1： | 1 |
| 9 | Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in exten- sive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann oncol2013，24，1： | 1 |
| 10 | 显示文摘 | Thide G Recke I | 1968 | J Less - Common Metals1968，14，： | 1 |
| 11 | Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-diseasesmall-cell lung cancer:results from a randomized,double-blind,multicenter phase 2 trial显示文摘 | Reck M Bondarenko I Luft A | 2013 | Ann Oncol2013，24，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员